Design of a Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy with High Tumor-to-Healthy-Tissue Ratios. Mukkamala R, Carlson DJ, Miller NK, Lindeman SD, et al. J Nucl Med 2024 Jun 13:jnumed.124.267756. doi: 10.2967/jnumed.124.267756.

Read + Share

Amedeo Smart

Independent Medical Education

Mukkamala R, Carlson DJ, Miller NK, Lindeman SD, et al. Design of a Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy with High Tumor-to-Healthy-Tissue Ratios. J Nucl Med 2024 Jun 13:jnumed.124.267756. doi: 10.2967/jnumed.124.267756.
PMID: 38871387